Cronos to convert some cultivation space, reports revenue growth

Ontario-based Cronos Group reported quarterly revenue of 12.7 million Canadian dollars ($9.6 million), an improvement over the previous quarter's CA$10.2 million but slightly lower than consensus estimates. The cannabinoid company's adjusted EBITDA loss widened quarter-over-quarter to CA$24 million. However, most of the company's sales came in the licensed producer-to-licensed producer market. Cronos also announced the conversion of some cultivation space to allow for the production and sale ...